Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Merck
AS
AscendedInvestor
Community Contributor
(Hold) No pipeline Homerun to replace keytruda. But aggressively acquiring.
They have no homerun drug to replace the 25 billion in revenue from keytruda. If they can postpone the keytruda patent loss or acquire more high revenue assets things could be more optimistic.
View narrative
US$63.00
FV
28.1% overvalued
intrinsic discount
-3.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
21 days ago
author updated this narrative
MINISO Group Holding
BE
Bejgal
Community Contributor
MINISO Group Holding will soar with a revenue surge of 17.1%
MINISO Investment Thesis This analysis is based on the MINISO 2024 Q4 and 2025 Q1 earnings call presentations and the provided transcript. # Catalysts MINISO has several key growth drivers that could meaningfully impact sales and earnings: Global Store Network Expansion: The primary catalyst is the aggressive and ongoing expansion of its store network, both in China and, more significantly, in overseas markets.
View narrative
US$32.86
FV
38.7% undervalued
intrinsic discount
17.10%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Wema Bank
WA
WaneInvestmentHouse
Community Contributor
Wema Bank Plc (H1 2025) - Solid Earnings Momentum and Balance Sheet Expansion Support Upside Potential
Wema Bank is delivering a compelling earnings recovery, underpinned by strong net interest income growth , recovering asset quality , and an expanding loan book. Catalysts driving the upside include: Net Interest Income Surge : A 105% YoY increase to ₦129.2 billion (H1 2025), fueled by aggressive asset re-pricing and increased lending activity, supported by a ₦225 billion growth in loans and advances (now ₦1.43 trillion).
View narrative
₦17.76
FV
35.1% overvalued
intrinsic discount
11.71%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
4
users have commented on this narrative
13
users have followed this narrative
Updated
narrative
Lafarge Africa
WA
WaneInvestmentHouse
Community Contributor
Lafarge Africa Plc Q2/H1 – Strong Profitability and Balance Sheet Resilience Amid Market Headwinds
Lafarge Africa Plc has delivered a strong financial performance for H1 2025, with significant revenue and profit growth driven by higher demand, margin expansion, and cost control. The company demonstrated robust operational efficiency , disciplined capital allocation, and maintained a healthy balance sheet.
View narrative
₦113.40
FV
28.3% overvalued
intrinsic discount
19.00%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
7
users have commented on this narrative
17
users have followed this narrative
Updated
narrative
DNA3
Doric Nimrod Air Three
HE
Henderson
Community Contributor
Doric Nimrod Air Three will distribute proceeds to shareholders post liquidation
The company said it intends to distribute the sale proceeds to shareholders along with the remaining cash holdings, net of any liquidation and other costs, as soon as possible after the last lease end date. It said payment to shareholders is currently expected to be made in the first quarter of 2026.
View narrative
UK£0.95
FV
33.9% undervalued
intrinsic discount
17.17%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
about 1 month ago
author updated this narrative
Presco
WA
WaneInvestmentHouse
Community Contributor
Presco Plc Delivers Explosive Earnings Growth in H1 2025 – A High-Yield, High-Confidence Investment Case
Presco Plc Delivers Explosive Earnings Growth in H1 2025 – A High-Yield, High-Confidence Investment Case Presco Plc’s H1 2025 results reveal a remarkable earnings story driven by record revenue growth, margin expansion, and consistent operational strength. With a 125.8% surge in revenue and a 128.2% boost in net profit, Presco has firmly established itself as a top-tier performer in Nigeria’s agro-industrial sector.
View narrative
₦1.26k
FV
17.4% overvalued
intrinsic discount
13.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
4
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
Okomu Oil Palm
WA
WaneInvestmentHouse
Community Contributor
Okomu Oil Palm Company Plc – Q2/H1 2025 Results
The company has demonstrated exceptional earnings growth in H1 2025, backed by operational leverage, prudent cost control , and a healthy balance sheet. Despite agricultural seasonality and inflationary pressures, Okomu Oil's performance suggests continued upside potential in the near-to-medium term.
View narrative
₦804.54
FV
30.5% overvalued
intrinsic discount
13.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
Nigerian Exchange Group
WA
WaneInvestmentHouse
Community Contributor
NGX Group Plc H1 2025 Result – Strong Profit Rebound, Strategic Position Intact
NGX Group Plc delivered a robust performance in H1 2025, posting profit after tax of ₦4.22 billion , representing a significant growth of 97% compared to ₦2.14 billion in H1 2024. This sharp rebound highlights the resilience of NGX’s diversified earnings streams and the strength of its capital market infrastructure business amidst recovering macroeconomic conditions.
View narrative
₦64.54
FV
7.3% overvalued
intrinsic discount
15.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
2
users have commented on this narrative
10
users have followed this narrative
Updated
narrative
Nestlé Nigeria
WA
WaneInvestmentHouse
Community Contributor
Nestlé Nigeria Delivers Strong Rebound with Triple-Digit Profit Growth in H1 2025
Nestlé Nigeria Plc has staged a remarkable recovery in H1 2025, reversing the prior year’s losses with impressive revenue and profit growth. A combination of robust top-line performance, margin expansion, and efficient cost control drove a swing from a ₦252.5 billion pre-tax loss in H1 2024 to an ₦88.4 billion profit in H1 2025.
View narrative
₦1.54k
FV
22.6% overvalued
intrinsic discount
5.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
3
users have commented on this narrative
1
users have followed this narrative
Updated
narrative
Value any company in seconds
Popular companies